Literature DB >> 32948866

The association between low lean mass and osteoporosis increases the risk of weakness, poor physical performance and frailty in Brazilian older adults: data from SARCOS study.

Alberto Frisoli1,2, Angela Tavares Paes3, Jairo Borges4,5, Sheila McNeill Ingham5, Monica Maria Cartocci4, Eliene Lima4, Antonio Carlos de Camargo Carvalho4.   

Abstract

PURPOSE: To characterize the phenotypes of older adults with low lean mass and osteoporosis, concomitantly or isolated, in regards to poor physical performance and frailty status.
DESIGN: Cross-sectional analysis of the SARCopenia and OSteoporosis in Older Adults with Cardiovascular Diseases Study (SARCOS).
SETTING: Outpatient geriatric cardiology clinic. PARTICIPANTS AND
METHOD: 385 older adults underwent DXA analysis. Low lean mass was diagnosed according to FNIH and low BMD by a T-score ≤ -2.5 SD. Subjects were grouped into: I-Low lean mass and Osteoporosis (LLMO); II-Low lean mass (LLM); III-Osteoporosis (OP), and IV-Controls. Poor physical performance was diagnosed by weakness or slow walking speed or impaired mobility. Frailty was diagnosed by CHS criteria.
RESULTS: The mean age was 78.22 ± 7.16 years. The prevalence of LLMO, LLM, and OP were 14.8%, 39.5%, and 19.2%, respectively. LLMO subjects were older, predominantly women, with a high percentage of body fat (HTBF). LLM was represented by obese men, while individuals with OP were preferably women, older and leaner. In a regression analyses, LLMO presented an OR: 6.42 (2.63‒15.65; p < 0.001) for weakness, OR: 2.55 (1.09‒5.95; p = 0.030) for impaired mobility, and OR: 14.75 (2.72‒79.94; p = 0.002) for frailty. After adjusting for HTBF, the OR for frailty, decreased to 7.25 (1.11-47.21; p = 0.038). LLM and OP were associated only with weakness with an OR: 3.06 (1.36-6.84; p = 0.006) and OR: 3.14 (1.29-7.62; p = 0.011), respectively.
CONCLUSION: In Brazilian older community-dwelling outpatient adults, the phenotype characterized by low lean mass and osteoporosis presents a higher association with impaired mobility, weakness and frailty status compared to the others phenotyeps and controls. A high percentage of body fat presents a synergistic effect with low lean mass and osteoporosis phenotype in regards to frailty.

Entities:  

Year:  2020        PMID: 32948866     DOI: 10.1038/s41430-020-00753-w

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  36 in total

Review 1.  Age and physical work capacity.

Authors:  R J Shephard
Journal:  Exp Aging Res       Date:  1999 Oct-Dec       Impact factor: 1.645

2.  Beyond FRAX: it's time to consider "sarco-osteopenia".

Authors:  Neil Binkley; Bjoern Buehring
Journal:  J Clin Densitom       Date:  2009-09-03       Impact factor: 2.617

3.  Muscle strength and body composition are clinical indicators of osteoporosis.

Authors:  Toni Rikkonen; Joonas Sirola; Kari Salovaara; Marjo Tuppurainen; Jukka S Jurvelin; Risto Honkanen; Heikki Kröger
Journal:  Calcif Tissue Int       Date:  2012-06-26       Impact factor: 4.333

4.  Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).

Authors:  C Roux; A Wyman; F H Hooven; S H Gehlbach; J D Adachi; R D Chapurlat; J E Compston; C Cooper; A Díez-Pérez; S L Greenspan; A Z Lacroix; J C Netelenbos; J Pfeilschifter; M Rossini; K G Saag; P N Sambrook; S Silverman; E S Siris; N B Watts; S Boonen
Journal:  Osteoporos Int       Date:  2012-03-08       Impact factor: 4.507

Review 5.  Muscle and bone, two interconnected tissues.

Authors:  Camille Tagliaferri; Yohann Wittrant; Marie-Jeanne Davicco; Stéphane Walrand; Véronique Coxam
Journal:  Ageing Res Rev       Date:  2015-03-21       Impact factor: 10.895

6.  Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia.

Authors:  Fulvio Lauretani; Cosimo Roberto Russo; Stefania Bandinelli; Benedetta Bartali; Chiara Cavazzini; Angelo Di Iorio; Anna Maria Corsi; Taina Rantanen; Jack M Guralnik; Luigi Ferrucci
Journal:  J Appl Physiol (1985)       Date:  2003-11

7.  Longitudinal changes in body composition in older men and women: role of body weight change and physical activity.

Authors:  Virginia A Hughes; Walter R Frontera; Ronenn Roubenoff; William J Evans; Maria A Fiatarone Singh
Journal:  Am J Clin Nutr       Date:  2002-08       Impact factor: 7.045

Review 8.  Muscle-bone interactions: From experimental models to the clinic? A critical update.

Authors:  Michaël R Laurent; Vanessa Dubois; Frank Claessens; Sabine M P Verschueren; Dirk Vanderschueren; Evelien Gielen; Ferran Jardí
Journal:  Mol Cell Endocrinol       Date:  2015-10-23       Impact factor: 4.102

Review 9.  Endocrine crosstalk between muscle and bone.

Authors:  Marco Brotto; Mark L Johnson
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

10.  Sarcopenia: burden and challenges for public health.

Authors:  Charlotte Beaudart; René Rizzoli; Olivier Bruyère; Jean-Yves Reginster; Emmanuel Biver
Journal:  Arch Public Health       Date:  2014-12-18
View more
  3 in total

1.  Measuring forearm bone density instead of lumbar spine bone density improves the sensitivity of diagnosing osteoporosis in older adults with cardiovascular diseases: Data from SARCOS study.

Authors:  Alberto Frisoli; Angela T Paes; Amanda Diniz Kimura; Elaine Azevedo; Valdir Ambrosio
Journal:  Bone Rep       Date:  2021-10-04

2.  The combination of osteoporosis and low lean mass correlates with physical function in end-stage knee osteoarthritis: A retrospective observational study.

Authors:  So Young Lee; Bo Ryun Kim; Sang Rim Kim; Jun Hwan Choi; Eui Jin Jeong; Jinseok Kim
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

3.  Associations of osteoporosis and sarcopenia with frailty and multimorbidity among participants of the Hertfordshire Cohort Study.

Authors:  Faidra Laskou; Nicholas R Fuggle; Harnish P Patel; Karen Jameson; Cyrus Cooper; Elaine Dennison
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-12-06       Impact factor: 12.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.